Semaglutide works by slowing stomach emptying and signaling fullness to your brain, but this metabolic shift can trigger temporary fatigue in many patients
KLOW remains a research-only tool
In doing so, we advocate for a paradigm that moves beyond traditional indications, embracing the full spectrum of GLP-1R agonists in areas such as primary prevention, microvascular protection, and metabolic liver disease, and metabolic disorders that include cardio-kidney-metabolic (CKM) syndromea systemic disorder characterized by interrelated metabolic, renal, and cardiovascular dysfunction and a broader cardio-renal-metabolic axis that includes central obesity, insulin resistance, dyslipidemia, hypertension, and pre-diabetic states
Kaneshwaran K et al (2019) Sleep fragmentation, microglial aging, and cognitive impairment in adults with and without Alzheimers dementia